Enanta Pharmaceuticals, Inc. (ENTA) Social Stream



Enanta Pharmaceuticals, Inc. (ENTA): $39.47

1.34 (+3.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ENTA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Enanta Pharmaceuticals Inc (ENTA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ENTA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 10 $121 $55 $89.777 $71.18 26.13%
2021-11-19 10 $121 $55 $89.555 $71.18 25.81%
2021-11-22 10 $111 $55 $88.444 $71.18 24.25%
2021-11-23 10 $111 $71 $89.666 $71.18 25.97%
2022-01-06 9 $116 $71 $89.555 $71.18 25.81%
2022-01-13 9 $116 $71 $89 $71.18 25.04%
2022-02-02 8 $116 $71 $89 $71.18 25.04%
2022-02-08 9 $116 $72 $91.25 $71.18 28.2%
2022-02-16 8 $116 $68 $88.875 $71.18 24.86%
2022-03-23 8 $116 $68 $87 $71.18 22.23%

The Trend in the Analyst Price Target


Over the past 22 months, ENTA's average price target has gone up $14.5.

Over the past 49 weeks, ENTA's average upside potential has been 32.49%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 5 107 35 68.140 47.62 43.09%
2021-08-02 8 107 35 66.000 42.55 55.11%
2021-09-19 8 107 35 65.330 58.43 11.81%
2021-11-22 10 111 55 88.444 75.18 17.64%
2022-02-02 8 116 71 89.000 58.66 51.72%

ENTA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 4 0 4 0 0 8

The Trend in the Broker Recommendations


Over the past 59 days, ENTA's average broker recommendation rating worsened by 0.11.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Enanta Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 115.31% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Enanta Pharmaceuticals Inc's average analyst price target is greater than 840.21% of them.
  • ENTA has a greater number of analysts covering the stock than 757.47% of Pharmaceutical Products stocks.
  • ENTA has a lower variance in analysts' estimates than -607.96% of stocks in the mid market cap category.

Stocks similar to Enanta Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EBS, DVAX, and DCPH.

Is ENTA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5783 seconds.